CTD_GIM https://blog.hatena.ne.jp/CTD_GIM/ 膠原病・リウマチ一人抄読会 https://ctd-gim.hatenablog.com/ ANCA関連血管炎 治療薬 Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial | Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases Published Online First: 11 December 2023. doi: 10.1136/ard-2023-224489 ANCA関連血管炎の維持療法はリツキシマブ（RTX）がスタン… 190 <iframe src="https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2023%2F12%2F19%2F192443" title="ANCA関連血管炎維持療法のRTXの指標はANCAとB細胞数どちらが良いか？(MAINTANCAVAS study) - 膠原病・リウマチ一人抄読会" class="embed-card embed-blogcard" scrolling="no" frameborder="0" style="display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;"></iframe> Hatena Blog https://hatena.blog 2023-12-19 19:24:43 rich https://ctd-gim.hatenablog.com/entry/2023/12/19/192443 1.0 100%